Literature DB >> 2445752

The primary structure of human chromogranin A and pancreastatin.

D S Konecki1, U M Benedum, H H Gerdes, W B Huttner.   

Abstract

A full-length clone encoding human chromogranin A has been isolated from a lambda gt10 cDNA library of a human pheochromocytoma. The nucleotide sequence reveals that human chromogranin A is a 439-residue protein preceded by an 18-residue signal peptide. Comparison of the protein sequence of human chromogranin A with that of bovine chromogranin A shows high conservation of the NH2-terminal and COOH-terminal domains as well as the potential dibasic cleavage sites, whereas the middle portion shows remarkable sequence variation (36%). This part of human chromogranin A contains a sequence homologous to porcine pancreastatin at residues 250-301. The sequence variation in this part of human chromogranin A compared to porcine pancreastatin is 32% and thus of the same magnitude as that between human and bovine chromogranin A. Therefore, the difference between porcine pancreastatin and the corresponding portions of bovine or human chromogranin A can be explained by species variation, suggesting that pancreastatin is derived from chromogranin A itself rather than a protein that is only similar to chromogranin A. Moreover, the pancreastatin sequence contained in human chromogranin A is flanked by sites for proteolytic processing. Together, these observations suggest that human chromogranin A may be the precursor for a human pancreastatin molecule and possibly for other, as yet unidentified, biologically active peptides.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445752

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

Review 1.  Catestatin: a multifunctional peptide from chromogranin A.

Authors:  Sushil K Mahata; Manjula Mahata; Maple M Fung; Daniel T O'Connor
Journal:  Regul Pept       Date:  2010-01-28

Review 2.  Biochemistry of the chromogranin A protein family.

Authors:  J P Simon; D Aunis
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

3.  Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method.

Authors:  Scott N Pinchot; Renata Jaskula-Sztul; Li Ning; Noel R Peters; Mackenzie R Cook; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

4.  Topology of chromogranins in secretory granules of endocrine cells.

Authors:  Y Cetin; D Grube
Journal:  Histochemistry       Date:  1991

5.  The tissue distribution of rat chromogranin A-derived peptides: evidence for differential tissue processing from sequence specific antisera.

Authors:  W J Curry; C F Johnston; J C Hutton; S D Arden; N G Rutherford; C Shaw; K D Buchanan
Journal:  Histochemistry       Date:  1991

6.  Novel autoantigens in type 1 diabetes.

Authors:  Shuhong Han; William Donelan; Hai Wang; Westley Reeves; Li-Jun Yang
Journal:  Am J Transl Res       Date:  2013-05-24       Impact factor: 4.060

Review 7.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

8.  Immunocytochemical localization of NCAM and catecholamine-synthesizing enzymes in rabbit intra- and extra-adrenal chromaffin tissue.

Authors:  A Moftaquir; K Langley; M J Boutroy
Journal:  Histochem J       Date:  1996-10

9.  Novel peptides from adrenomedullary chromaffin vesicles.

Authors:  J Sigafoos; W G Chestnut; B M Merrill; L C Taylor; E J Diliberto; O H Viveros
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

10.  Nucleotide and deduced amino acid sequence of bovine adrenal medulla chromogranin B (secretogranin I).

Authors:  D K Grandy; R Leduc; H Makam; T Flanagan; E J Diliberto; O Civelli; O H Viveros
Journal:  Cell Mol Neurobiol       Date:  1992-04       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.